Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
M01AB11
CAS registry number (Chemical Abstracts Service)
0053164-05-9
Chemical Formula
C21-H18-Cl-N-O6
Molecular Weight
415
Therapeutic Categories
Analgesic, antipyretic and anti-inflammatory agent
Non-steroidal anti-inflammatory drug, NSAID
Chemical Name
1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, carboxymethyl ester
Foreign Names
- Acemetacinum (Latin)
- Acemetacin (German)
- Acémétacine (French)
- Acemetacina (Spanish)
Generic Names
- Acemetacin (OS: JAN, BAN)
- Acemetacina (OS: DCIT)
- Bay f 4975 (IS: Bayer)
- K 708 (IS: Kowa)
- TVX 1322 (IS)
- Acemetacin (PH: Ph. Eur. 6, JP XV, BP 2010)
- Acemetacinum (PH: Ph. Eur. 6)
Brand Names
- Acemet
Synmosa, Taiwan - Acemetacin Heumann
Heumann, Germany - Acemetacin KSK
KSK-Pharma, Germany - Acemetacin Stada
Stada, Germany - Acemetacin-CT
CT Arzneimittel, Germany - Aceo
U.C. Pharma, Taiwan - Baydol
Bayer, Colombia - Cobametacin
Kobayashi Kako, Japan - Emflex
Merck Serono, United Kingdom - Flamarion
Pharma Investi, Chile - Gamespir
Cosmopharm, Greece - Mocetasin
Jin Yang Pharm, Vietnam - Pranex
Bayer, Ecuador; Bayer, Peru - Rantudal
Menarini, Greece - Rantudil Kowa
Kowa Souyaku, Japan - Rantudil
Bayer, Costa Rica; Bayer, Dominican Republic; Bayer, Guatemala; Bayer, Honduras; Bayer, Mexico; Bayer, Nicaragua; Bayer, Panama; Bayer, Philippines; Bayer, Poland; Bayer, Romania; Bayer, El Salvador; Bayer, Turkey; Bial, Portugal; Meda, Germany; Meda, Hungary; Meda, Luxembourg; Meda, Malta; Tropon, Luxembourg; Tropon, Serbia - Rheutrop
Meda, Austria - Tilur
Drossapharm, Switzerland
International Drug Name Search
Glossary
BAN | British Approved Name |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment